AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MACH7 TECHNOLOGIES LIMITED Regulatory Filings 2016

Aug 2, 2016

65285_rns_2016-08-02_f66e8c21-8f29-484b-92a7-d755dcd64149.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

ASX Announcement

3 August 2016

==> picture [610 x 89] intentionally omitted <==

Market Update

Melbourne, Australia; 3 August 2016: Mach7 Technologies Limited ( Mach7 ) (ASX: M7T ), a recognised leader in the enterprise imaging market, confirms the customer referred to in the Company’s announcement dated 2 August 2016 is Virginia Commonwealth University Health System Authority.

-ENDS

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) develops innovative enterprise imaging IT solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit www.mach7t.com.

About 3D Medical:

Mach7’s wholly-owned subsidiary, 3D Medical Pty Limited, provides medical specific 3D printing and is an exclusive distributor of various synergistic technologies including holographic projection. 3D Medical’s innovative products leverage data already captured by conventional imaging modalities and apply it in more meaningful ways to deliver improved economic and patient outcomes. For more information, visit www.3dmedical.com.au